Cargando…
P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DARIA STUDY
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430904/ http://dx.doi.org/10.1097/01.HS9.0000970508.43614.c0 |
| _version_ | 1785091071296929792 |
|---|---|
| author | Terpos, Evangelos Gavriatopoulou, Maria Katodritou, Eirini Hatjiharissi, Evdoxia Dialoupi, Ioanna Verrou, Evgenia Manousou, Kyriaki Gkolfinopoulos, Stavros Migkou, Magdalini Delimpasi, Sosana Symeonidis, Argiris Kastritis, Efstathios Dimopoulos, Meletios A. |
| author_facet | Terpos, Evangelos Gavriatopoulou, Maria Katodritou, Eirini Hatjiharissi, Evdoxia Dialoupi, Ioanna Verrou, Evgenia Manousou, Kyriaki Gkolfinopoulos, Stavros Migkou, Magdalini Delimpasi, Sosana Symeonidis, Argiris Kastritis, Efstathios Dimopoulos, Meletios A. |
| author_sort | Terpos, Evangelos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430904 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309042023-08-17 P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DARIA STUDY Terpos, Evangelos Gavriatopoulou, Maria Katodritou, Eirini Hatjiharissi, Evdoxia Dialoupi, Ioanna Verrou, Evgenia Manousou, Kyriaki Gkolfinopoulos, Stavros Migkou, Magdalini Delimpasi, Sosana Symeonidis, Argiris Kastritis, Efstathios Dimopoulos, Meletios A. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430904/ http://dx.doi.org/10.1097/01.HS9.0000970508.43614.c0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Terpos, Evangelos Gavriatopoulou, Maria Katodritou, Eirini Hatjiharissi, Evdoxia Dialoupi, Ioanna Verrou, Evgenia Manousou, Kyriaki Gkolfinopoulos, Stavros Migkou, Magdalini Delimpasi, Sosana Symeonidis, Argiris Kastritis, Efstathios Dimopoulos, Meletios A. P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DARIA STUDY |
| title | P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DARIA STUDY |
| title_full | P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DARIA STUDY |
| title_fullStr | P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DARIA STUDY |
| title_full_unstemmed | P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DARIA STUDY |
| title_short | P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DARIA STUDY |
| title_sort | p901: daratumumab, ixazomib and dexamethasone in patients with relapsed/refractory multiple myeloma pre-treated with a lenalidomide-based regimen: final outcomes of the phase 2 daria study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430904/ http://dx.doi.org/10.1097/01.HS9.0000970508.43614.c0 |
| work_keys_str_mv | AT terposevangelos p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT gavriatopouloumaria p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT katodritoueirini p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT hatjiharissievdoxia p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT dialoupiioanna p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT verrouevgenia p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT manousoukyriaki p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT gkolfinopoulosstavros p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT migkoumagdalini p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT delimpasisosana p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT symeonidisargiris p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT kastritisefstathios p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy AT dimopoulosmeletiosa p901daratumumabixazomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyelomapretreatedwithalenalidomidebasedregimenfinaloutcomesofthephase2dariastudy |